Sensus Healthcare (SRTS) Cash from Financing Activities (2017 - 2025)
Sensus Healthcare's (SRTS) quarterly Cash from Financing Activities came in at -$5000.0 in Q4 2025, down 117.86% year-on-year from $28000.0 in Q4 2024, and up 98.33% quarter-over-quarter from -$300000.0 in Q1 2025.
Sensus Healthcare (SRTS) Cash from Financing Activities (2017 - 2025) Analysis & Trends
Sensus Healthcare's Cash from Financing Activities history runs 9 years deep, the most recent figure standing at -$5000.0 for Q4 2025.
- On a quarterly basis, Cash from Financing Activities fell 117.86% year-over-year to -$5000.0 in Q4 2025; TTM through Dec 2025 was -$305000.0, a 535.42% decrease from a year earlier, with the FY2025 full-year figure at -$305000.0, down 2133.33% from the prior year.
- Cash from Financing Activities climbed to -$5000.0 in Q4 2025 per SRTS's latest filing, from -$300000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $273000.0 in Q1 2022 and bottomed at -$1.9 million in Q4 2022.
- The 5-year median for Cash from Financing Activities is -$39000.0 (2023), against an average of -$200400.0.
- Biggest YoY gain for Cash from Financing Activities was 555.0% in 2022; the steepest drop was 3481.48% in 2022.
- Year by year, Cash from Financing Activities stood at -$54000.0 in 2021, then tumbled by 3481.48% to -$1.9 million in 2022, then surged by 99.64% to -$7000.0 in 2023, then jumped by 500.0% to $28000.0 in 2024, then plunged by 117.86% to -$5000.0 in 2025.
- Per Business Quant, the three latest SRTS Cash from Financing Activities figures stand at -$5000.0 (Q4 2025), -$300000.0 (Q1 2025), and $28000.0 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sensus Healthcare | 50.14 Mn | 31.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Mar 31, 2025 | -300,000.00 |
| Mar 31, 2025 | -300,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Sep 30, 2023 | -39,000.00 |
| Sep 30, 2023 | -39,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Dec 31, 2022 | -1.93 Mn |
| Dec 31, 2022 | -1.93 Mn |
| Sep 30, 2022 | 211,000.00 |
| Sep 30, 2022 | 211,000.00 |
| Jun 30, 2022 | -978,000.00 |
| Jun 30, 2022 | -978,000.00 |